Sign in
Taking peopleNo phase

Tracking blood sugar changes in women having fertility treatment

Watches blood sugar with a worn sensor in women having assisted reproduction.

Key facts

Who runs it
Shanghai 6th People's Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring
Status
Recruiting
People taking part
100 people, planned
Started
26 Mar 2025
Expected to end
30 Apr 2027
Type of study
Interventional
Treatments tested
  • CGM
Record updated
23 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with infertility who will start their first or second IVF/ICSI cycle at the study center. They will wear glucose sensors during treatment.

Age
18 to 40 years
Sex
Women only
Disease stage
Female infertility, first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI).
Earlier treatment
The chosen ovarian stimulation plan must be the GnRH antagonist regimen or the PPOS regimen. People who recently had glucocorticoid treatment or chemotherapy cannot join.

Main reasons for not taking part

  • Recent infections (viral infections of the reproductive system such as HPV are allowed)
  • Recent glucocorticoid treatment or chemotherapy
  • Repeated implantation failure, repeated miscarriage, removal of one ovary, uterine malformations, or abnormal parental chromosomes (karyotype)
  • Cannot tolerate or is allergic to the sensor's adhesive tape
  • Serious skin disease around the sensor area, such as psoriasis vulgaris or bacterial skin infection

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Informed consent and voluntary participation in this study
  • Age ≥ 18 years and ≤40 years old
  • Infertile patients who will undergo their first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) at the study center
  • The chosen ovulation promotion regimens is the GnRH antagonist regimen/progesterone-promoting ovulation under hyperprogesterone state (PPOS) regimen

Who cannot take part

  • Recent glucocorticoid treatment or chemotherapy
  • Recent infections (excluding viral infections of the reproductive system such as HPV)
  • Clinical conditions affecting the outcome of assisted reproduction, including repeated implantation failure, recurrent spontaneous abortion, history of unilateral oophorectomy, uterine malformations, and parental karyotype abnormalities
  • Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

No studies have been seen on glucose variation during medication for assisted reproduction. The aim of this study is to continuously observe glucose variation during assisted reproduction treatment using continuous glucose monitoring (CGM), and to further explore whether glucose variation will affect the outcomes related to assisted reproduction.

The group in the trial

  • wearing continuous glucose monitoringsTreatment being tested

    Patients will wear two FreeStyle Libre Pro Flash CGM (Abbott Diabetes Care, Alameda, CA, USA) to ensure continuous tracking of blood glucose levels at key time points throughout the ovarian stimulation.

    Treatment: CGM

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring
Plain-language title
Tracking blood sugar changes in women having fertility treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT06863337, who can take part
Record updated
23 December 2025